XML 28 R14.htm IDEA: XBRL DOCUMENT v3.10.0.1
Goodwill and Intangible Assets
 12 Months Ended
Dec. 31, 2018
Goodwill and Intangible Assets Disclosure [Abstract]  
Goodwill and Intangible Assets
Goodwill and Intangible Assets
Goodwill
The following table represents changes in the carrying amount of goodwill:
 
Automation and
Analytics
 
Medication
Adherence
 
Total
 
(In thousands)
Net balance as of December 31, 2016
$
215,082

 
$
112,642

 
$
327,724

Additions (1)
3,113

 
3,400

 
6,513

Adjustments (2)
2,656

 
858

 
3,514

Net balance as of December 31, 2017
220,851

 
116,900

 
337,751

Adjustments (2)
(1,296
)
 
(568
)
 
(1,864
)
Net balance as of December 31, 2018
$
219,555

 
$
116,332

 
$
335,887

_________________________________________________
(1) 
Additions to goodwill in the Automation and Analytics segment was a result of the InPharmics acquisition in April 2017. Additions to goodwill in the Medication Adherence segment represent adjustments to the preliminary value assigned to goodwill in connection with the Ateb acquisition to reflect measurement period adjustments related to accounts receivable, other non-current assets, and other liabilities of $0.1 million, $0.7 million and $2.6 million, respectively.
(2) 
Adjustments reflect foreign currency exchange rate fluctuations.
Intangible Assets, Net
The carrying amounts of intangible assets and useful lives as of December 31, 2018 and December 31, 2017 were as follows:
 
December 31, 2018
 
Gross
carrying
amount
 
Accumulated
amortization
 
Foreign currency exchange rate fluctuations
 
Net
carrying
amount
 
Useful life
(years)
 
(In thousands, except for years)
Customer relationships
$
135,234

 
$
(45,029
)
 
$
(1,185
)
 
$
89,020

 
1 - 30
Acquired technology
78,122

 
(29,206
)
 
42

 
48,958

 
3 - 20
Backlog
21,350

 
(20,703
)
 
—

 
647

 
1 - 4
Trade names
7,650

 
(4,361
)
 
17

 
3,306

 
1 - 12
Patents
3,239

 
(1,488
)
 
4

 
1,755

 
2 - 20
Non-compete agreements
1,900

 
(1,900
)
 
—

 
—

 
3
Total intangibles assets, net
$
247,495

 
$
(102,687
)
 
$
(1,122
)
 
$
143,686

 
 

 
December 31, 2017
 
Gross carrying
amount
 
Accumulated
amortization
 
 Foreign currency exchange rate fluctuations
 
Net
carrying
amount
 
Useful life
(years)
 
(In thousands, except for years)
Customer relationships
$
135,234

 
$
(33,988
)
 
$
(787
)
 
$
100,459

 
1 - 30
Acquired technology
74,222

 
(21,345
)
 
221

 
53,098

 
3 - 20
Backlog
21,350

 
(17,182
)
 
—

 
4,168

 
1 - 4
Trade names
7,650

 
(3,688
)
 
40

 
4,002

 
1 - 12
Patents
3,239

 
(1,369
)
 
10

 
1,880

 
2 - 20
Non-compete agreements
1,900

 
(1,300
)
 
—

 
600

 
3
In-process technology
3,900

 
—

 
—

 
3,900

 
—
Total intangibles assets, net
$
247,495

 
$
(78,872
)
 
$
(516
)
 
$
168,107

 
 

During the year ended December 31, 2018, the Company reclassified in-process research and development intangible assets of $3.9 million to acquired technology due to the completion of a certain project.
Amortization expense of intangible assets was $23.8 million, $25.6 million, and $36.1 million for the years ended December 31, 2018, December 31, 2017, and December 31, 2016, respectively.
The estimated future amortization expenses for amortizable intangible assets were as follows:
 
December 31, 2018
 
(In thousands)
2019
$
18,832

2020
17,625

2021
16,279

2022
14,926

2023
13,793

Thereafter
62,231

Total
$
143,686